Skip to main content
. 2018 Nov 15;104(4):835–843. doi: 10.3324/haematol.2018.202754

Figure 1.

Figure 1.

The cumulative incidence of chronic graft-versus-host disease is higher in the mismatched unrelated donor group than in the cord blood or HLA-haploidentical groups, but survival does not differ between the groups. Cumulative incidence of (A) chronic graft-versus-host disease and (B) progression-free survival after transplant according to alternative donor hematopoietic cell transplant group. NIH: National Institutes of Health; cGVHD: chronic graft-versus-host disease; URD Mism: mismatched unrelated donor; Cord: umbilical cord blood; Haplo: haplorelated bone marrow or peripheral blood; PFS: progression-free survival.